Trial Profile
A retrospective study to evaluate sorafenib in elderly patients with hepatocellular carcimoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Sep 2015
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 16 Sep 2015 New trial record